448 related articles for article (PubMed ID: 27632981)
21. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
[TBL] [Abstract][Full Text] [Related]
22. Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C.
Nadeem A; Aslam M; Khan DA; Hussain T; Khan SA
J Coll Physicians Surg Pak; 2009 Feb; 19(2):86-9. PubMed ID: 19208310
[TBL] [Abstract][Full Text] [Related]
23. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.
Bohbot NL; Young J; Orgiazzi J; Buffet C; François M; Bernard-Chabert B; Lukas-Croisier C; Delemer B
Eur J Endocrinol; 2006 Mar; 154(3):367-72. PubMed ID: 16498048
[TBL] [Abstract][Full Text] [Related]
24. Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves' disease.
Braga-Basaria M; Basaria S
J Endocrinol Invest; 2003 Mar; 26(3):261-4. PubMed ID: 12809178
[TBL] [Abstract][Full Text] [Related]
25. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
[TBL] [Abstract][Full Text] [Related]
26. Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin.
Ridruejo E; Christensen AF; Mando OG
Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):693-4. PubMed ID: 16702862
[TBL] [Abstract][Full Text] [Related]
27. [Autoimmune dysthyroidism induced by alpha interferon in two female patients with chronic non-A, non-B hepatitis].
Eugène C; Tennenbaum R; Anciaux ML; Quevauvilliers J; Bergue A
Gastroenterol Clin Biol; 1993; 17(8-9):594-7. PubMed ID: 8253318
[TBL] [Abstract][Full Text] [Related]
28. Difficulties in diagnosing and managing coexisting primary hypothyroidism and resistance to thyroid hormone.
Tran HA
Endocr Pract; 2006; 12(3):288-93. PubMed ID: 16772202
[TBL] [Abstract][Full Text] [Related]
29. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment.
Minelli R; Braverman LE; Giuberti T; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Roti E
Clin Endocrinol (Oxf); 1997 Sep; 47(3):357-61. PubMed ID: 9373459
[TBL] [Abstract][Full Text] [Related]
30. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
[TBL] [Abstract][Full Text] [Related]
32. [Interferon-induced autoimmune thyroiditis in a patient with hepatitis C virus infection].
Pinto JL; Pinto ME
Rev Peru Med Exp Salud Publica; 2011 Jun; 28(2):382-4. PubMed ID: 21845321
[TBL] [Abstract][Full Text] [Related]
33. Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C.
Pittau E; Bogliolo A; Tinti A; Mela Q; Ibba G; Salis G; Perpignano G
Clin Exp Rheumatol; 1997; 15(4):415-9. PubMed ID: 9272304
[TBL] [Abstract][Full Text] [Related]
34. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
Shen L; Bui C; Mansberg R; Nguyen D; Alam-Fotias S
Clin Nucl Med; 2005 Aug; 30(8):546-7. PubMed ID: 16024950
[TBL] [Abstract][Full Text] [Related]
35. Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.
Kiehne K; Kloehn S; Hinrichsen H; Gallwitz B; Mönig H
Endocrine; 1997 Jun; 6(3):231-4. PubMed ID: 9368677
[TBL] [Abstract][Full Text] [Related]
36. Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin.
Paraná R; Cruz M; Santos-Jesus R; Ferreira K; Codes L; Cruz T
Braz J Infect Dis; 2000 Dec; 4(6):284-90. PubMed ID: 11136525
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
Doi F; Kakizaki S; Takagi H; Murakami M; Sohara N; Otsuka T; Abe T; Mori M
Liver Int; 2005 Apr; 25(2):242-6. PubMed ID: 15780045
[TBL] [Abstract][Full Text] [Related]
38. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Grazi G; Bernardi M; Andreone P
Gut; 2007 Feb; 56(2):237-42. PubMed ID: 16798778
[TBL] [Abstract][Full Text] [Related]
39. Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy.
Costelloe SJ; Wassef N; Schulz J; Vaghijiani T; Morris C; Whiting S; Thomas M; Dusheiko G; Jacobs M; Vanderpump MP
Clin Endocrinol (Oxf); 2010 Aug; 73(2):249-56. PubMed ID: 20148905
[TBL] [Abstract][Full Text] [Related]
40. Endocrine evaluation in patients treated with interferon-alpha for chronic hepatitis C.
Del Monte P; Bernasconi D; De Conca V; Randazzo M; Meozzi M; Badaracco B; Mesiti S; Marugo M
Horm Res; 1995; 44(3):105-9. PubMed ID: 7590639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
